Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hematology/Oncology

RSS  

Articles

  • Full February 2006 issue in PDF

  • Clinical Briefs in Primary Care supplement

  • Pharmacology Watch

    Letrozole for Postmenopausal Women with Breast Cancer; Do Antidepressants Increase Risk of Suicide?; Can Viagra Improve Heart Function?; Can Tamoxifen Increase Your Height?; A Dramatic Increase of Clostridium difficile; FDA Actions
  • Prostate Cancer Screening Part II: Treatment and Outcomes

    Prostate cancer is one of the leading causes of cancer in men, both in this country and in Europe. Recognizing that the primary care physician often is the first health care professional who determines whether a PSA test is ordered and often is crucial in directing further follow-up relating to diagnosis and treatment selection, Part II will deal with important information regarding the choices for treating prostate cancer, and the side effects, efficacy, and quality-of-life issues that result from treatment.
  • Full January 2006 Issue in PDF

  • From mandate to shortage: How do you prioritize?

    If you have scarce supplies of influenza vaccine, which health care workers (HCWs) would you immunize? Not an easy question, and the answers will certainly vary by institution.
  • Flu fight: A move to mandate vaccination leads to nurse standoff

    In the intensifying effort to immunize more health care workers against influenza, a precedent-setting battle is taking shape at Virginia Mason Medical Center (VMMC) in Seattle. In what is thought to be the first hospital in the United States to take such action, Virginia Mason officials have mandated annual flu shots as a condition of health care employment.
  • Journal Reviews

    Reports to the federal vaccine adverse event reporting system (VAERS) in the first two seasons of trivalent live, attenuated influenza vaccine (LAIV-T) use did not identify any unexpected serious risks with the vaccine when used according to approved indications, the authors report.
  • Abstract & Commentary: Weigh the cons against probiotics

    Synopsis: Three ICU patients receiving Saccharomyces boulardii (cerevisiae) therapy for treatment of Clostridium difficile colitis experienced fungemia. Review of 60 cases of S. cerevisiae fungemia reported in the literature found that risk factors included presence of a central venous catheter, intravenous or enteral alimentation, and receipt of S. cerevisiae as a probiotic.
  • C. diff strain strikes people in community

    Clostridium difficile continues to emerge in a more pathogenic form with a new epidemiological profile. Particularly disturbing are new reports in four states of infections in patients previously thought to be at low risk for C. diff.